<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: A test involving intravenous infusion of <z:chebi fb="2" ids="28918">epinephrine</z:chebi> has been proposed as a method alternative to exercise stress test in diagnosis of catecholaminergic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CPVT</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed at estimating the predictive value of intravenous <z:chebi fb="2" ids="28918">epinephrine</z:chebi> administration in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CPVT</z:e> patients with frequent exercise-induced ventricular ectopy </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We recruited 81 subjects, including 25 CPVT-linked <z:chebi fb="0" ids="8925">ryanodine</z:chebi> receptor 2 (RYR2) mutation carriers, 11 genetically undefined <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CPVT</z:e> patients, and 45 unaffected family members </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects underwent a maximal exercise stress test and an intravenous <z:chebi fb="2" ids="28918">epinephrine</z:chebi> infusion test </plain></SENT>
<SENT sid="4" pm="."><plain>Exercise stress test was positive in 25 (31%) patients including 14 of 25 (56%) established RYR2-mutation carriers and <z:hpo ids='HP_0000001'>all</z:hpo> 11 (100%) genetically undefined <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CPVT</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="2" ids="28918">Epinephrine</z:chebi> infusion induced <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in 3 (12%) RYR2-mutation carriers, 4 (36%) genetically undefined <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CPVT</z:e> patients, and 1 (2%) unaffected family member </plain></SENT>
<SENT sid="6" pm="."><plain>A total of 18 exercise stress test positive patients did not respond to intravenous <z:chebi fb="2" ids="28918">epinephrine</z:chebi> administration, whereas only 1 epinephrine test responder had a <z:mpath ids='MPATH_458'>normal</z:mpath> exercise stress test </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, if exercise stress test is used as a standard, the sensitivity of the <z:chebi fb="2" ids="28918">epinephrine</z:chebi> infusion test is 28% and specificity is 98% </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Intravenous <z:chebi fb="2" ids="28918">epinephrine</z:chebi> infusion has low sensitivity and may not be considered as an alternative method for a maximal exercise stress test in diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CPVT</z:e> </plain></SENT>
</text></document>